Clinical Trials Browser

Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Hematologic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Limited Stage Small Cell Lung Cancer

Small Cell Lung Cancer Extensive Stage

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Esophageal Neoplasms

Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Neoplasm Metastasis, Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Neuroblastoma

Nasopharyngeal Carcinoma

Pathologic Complete Response, Nasopharyngeal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Colorectal Neoplasms

Cutaneous Squamous Cell Carcinoma (CSCC)

Esophageal Squamous Cell Carcinoma

Uterine Cervical Neoplasms

Advanced Solid Tumor

Carcinoma, Non-Small-Cell Lung

Muscle-Invasive Bladder Carcinoma

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Pancreatic Neoplasms

Esophageal Neoplasms

Clinical Trials

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

MelPORT

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

SKY

InDuRanS

SCR-ESCC-01

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Neoadjuvant Treatment Modalities in Esophageal Cancer

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

SABR-SYNC

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

PACCELIO

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

PANCARDINAL-2

Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

DBPilot

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

MATISSE 2

ONTRESCC

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC

EFFORT-MIBC

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

OPPRESS

ICONIC

CYCLE

Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy